Compounds > n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine

Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and dihydropyridines

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with dihydropyridines in 11 studies

Compound Research Comparison

Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)	Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)	Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)	Studies (dihydropyridines)	Trials (dihydropyridines)	Recent Studies (post-2010) (dihydropyridines)
214	5	58	5,022	529	969

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (27.27)	18.2507
2000's	8 (72.73)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbracchio, MP; Jacobson, KA; Jiang, JL; Kim, YC; Sei, Y; Yao, Y	1
Jacobson, KA; Jiang, JL; Liang, BT; Stambaugh, K	1
Jahania, MS; Kraft, KR; Lasley, RD; Mentzer, RM; Narayan, P; Partin, EL	1
Abbracchio, MP; Barbieri, D; Brambilla, R; Cattabeni, F; Ceruti, S; Franceschi, C; Jacobson, KA; Kim, YC; Klotz, KN; Lohse, MJ	1
Kim, KT; Kim, TD; Lee, JU; Seong, JK; Suh, BC	1
de Zeeuw, S; Duncker, DJ; Liem, DA; van den Doel, MA; Verdouw, PD	1
Avila, MY; Civan, MM; Stone, RA	1
Kukreja, RC; Zhao, TC	1
Galun, E; Matot, I; Rivo, J; Zeira, E	1
Church, JE; Coupar, IM; Pouton, CW; Rose'Meyer, RB; Urmaliya, VB; White, PJ	1
Alhaj, M; Bozarov, A; Christofi, FL; Cooke, HJ; Grants, I; Hassanain, HH; Ren, T; Wang, YZ; Wunderlich, J; Yu, JG	1

Other Studies

11 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and dihydropyridines

Article	Year
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists. Biochemical and biophysical research communications, 1997, Mar-17, Volume: 232, Issue:2 Topics: Adenosine; Apoptosis; Dihydropyridines; DNA Fragmentation; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Quinazolines; Triazoles	1997
A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia. The American journal of physiology, 1997, Volume: 273, Issue:1 Pt 2 Topics: Adenosine; Animals; Cardiotonic Agents; Cell Hypoxia; Cells, Cultured; Chick Embryo; Dihydropyridines; Heart; Heart Ventricles; Myocardial Ischemia; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Xanthines	1997
Species-dependent hemodynamic effects of adenosine A3-receptor agonists IB-MECA and Cl-IB-MECA. The American journal of physiology, 1999, Volume: 276, Issue:6 Topics: Adenosine; Animals; Coronary Circulation; Coronary Vessels; Dihydropyridines; Female; Hemodynamics; In Vitro Techniques; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity; Swine; Triazoles; Vasodilation	1999
Activation of the A3 adenosine receptor affects cell cycle progression and cell growth. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:3 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Analysis of Variance; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Membrane; Cell Survival; CHO Cells; Cricetinae; Dihydropyridines; Flow Cytometry; Humans; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A3; Receptors, Purinergic P1; Transfection; Triazoles	2000
Pharmacological characterization of adenosine receptors in PGT-beta mouse pineal gland tumour cells. British journal of pharmacology, 2001, Volume: 134, Issue:1 Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Calcium; Colforsin; Cyclic AMP; Dihydropyridines; Dose-Response Relationship, Drug; Enzyme Activation; Estrenes; Gene Expression Regulation, Neoplastic; GTP-Binding Proteins; Inositol 1,4,5-Trisphosphate; Isoproterenol; Mice; Mice, Inbred CBA; Pertussis Toxin; Phospholipases; Pinealoma; Pyrrolidinones; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella	2001
Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors. Cardiovascular research, 2001, Volume: 51, Issue:4 Topics: Acetamides; Adenosine; Analysis of Variance; Animals; Cryoprotective Agents; Dihydropyridines; Histamine H1 Antagonists; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Purinergic Antagonists; Purinergic P1 Receptor Antagonists; Pyrilamine; Rats; Rats, Wistar; Receptors, Purinergic; Receptors, Purinergic P1; Theophylline; Time Factors	2001
Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:9 Topics: Adenosine; Administration, Topical; Animals; Dihydropyridines; Intraocular Pressure; Mice; Mice, Inbred C57BL; Mice, Knockout; Ophthalmic Solutions; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1	2002
Protein kinase C-delta mediates adenosine A3 receptor-induced delayed cardioprotection in mouse. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 285, Issue:1 Topics: Adenosine; Alkaloids; Animals; Benzophenanthridines; Blotting, Western; Cell Nucleus; Cytosol; Dihydropyridines; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Heart Diseases; Heart Function Tests; In Vitro Techniques; Isoenzymes; Male; Mice; Myocardial Contraction; Myocardial Infarction; NF-kappa B; Phenanthridines; Protein Kinase C; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1	2003
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion. Anesthesiology, 2004, Volume: 101, Issue:5 Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury	2004
Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine. Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:5 Topics: Acetamides; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Aminopyridines; Animals; Apoptosis; Cardiotonic Agents; Cell Line; Cell Survival; Dihydropyridines; Imidazoles; Myocardial Ischemia; Phenethylamines; Purines; Rats; Triazines; Triazoles; Xanthines	2009
Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine. American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 297, Issue:6 Topics: Adenosine; Animals; Chlorides; Cimetidine; Colon; Dihydropyridines; Dimaprit; Dose-Response Relationship, Drug; Enteric Nervous System; Gastrointestinal Motility; Guinea Pigs; Histamine; Histamine Agonists; Histamine H2 Antagonists; In Vitro Techniques; Intestinal Secretions; Male; Mecamylamine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Neural Inhibition; Neurogenic Bowel; Neurokinin-1 Receptor Antagonists; Nicotinic Antagonists; Piperidines; Propane; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Histamine H2; Receptors, Neurokinin-1; Reflex; Theophylline; Xanthines	2009